CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
CervoMed Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.31+0.07 (+3.12%)
Close on Oct 19, 2026
- Market cap
- $23.66M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
11.6%
2M of 15M shares
Institutional holders
37
7 new, 5 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
19 buys · 0 sales
Net bought $3.74M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| RA Capital Management, L.P. | 916,063 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Woodline Partners LP | 688,987 | 5.10% | 13G (passive) | Jun 30, 2026 |
| Boger Joshua S | 2,204,143 | 20.00% | 13D (active) amendment | Jun 11, 2026 |
| Steven Boyd | 1,592,863 | 9.53% | 13G (passive) | Jun 30, 2026 |
| Peter Kolchinsky | 1,266,143 | 8.60% | 13G (passive) amendment | Jun 30, 2026 |
| RA Capital Healthcare Fund, L.P. | 1,026,937 | 9.90% | 13G (passive) amendment | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CRVO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Woodline Partners LP | 688,987 | 4.56% | $2.14M | New | 0.01% |
| Vanguard Capital Management LLC | 316,202 | 2.09% | $980.23K | – | 0.00% |
| Sabby Management, LLC | 248,880 | 1.65% | $771.53K | New | 0.70% |
| Geode Capital Management, LLC | 66,923 | 0.44% | $207.52K | −7,448 | 0.00% |
| BlackRock, Inc. | 53,845 | 0.36% | $166.92K | +2,185 | 0.00% |
| Byrne Asset Management LLC | 51,250 | 0.34% | $158.88K | +36,550 | 0.09% |
| Citizens Financial Group Inc/Ri | 37,477 | 0.25% | $116.18K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 36,151 | 0.24% | $112.07K | – | 0.00% |
| Jane Street Group, LLC | 32,231 | 0.21% | $99.92K | +13,985 | 0.00% |
| Thompson Davis & Co., Inc. | 29,750 | 0.20% | $92.23K | +19,750 | 0.06% |
| Savvy Advisors, Inc. | 25,922 | 0.17% | $80.36K | – | 0.00% |
| Virtu Financial LLC | 24,093 | 0.16% | $75 | New | 0.00% |
| State Street Corp | 20,527 | 0.14% | $63.63K | – | 0.00% |
| Cetera Investment Advisers | 19,622 | 0.13% | $60.83K | −7,715 | 0.00% |
| Summit Financial, LLC | 18,140 | 0.12% | $56.23K | New | 0.00% |
| Russell Investments Group, Ltd. | 15,363 | 0.10% | $47.63K | −727 | 0.00% |
| Northern Trust Corp | 13,318 | 0.09% | $41.29K | −16,726 | 0.00% |
| Morgan Stanley | 12,699 | 0.08% | $39.37K | −727,193 | 0.00% |
| HighTower Advisors, LLC | 11,919 | 0.08% | $36.95K | +654 | 0.00% |
| FMR LLC | 10,538 | 0.07% | $32.67K | −502 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 37 | 2M | 11.6% | 7 / 9 | 8 / 5 | 1M | 1M |
| Q1 2026 | 36 | 2M | 11.7% | 6 / 10 | 6 / 17 | 1M | 1M |
| Q4 2025 | 48 | 2M | 14.6% | 9 / 11 | 16 / 6 | 0M | 0M |
| Q3 2025 | 45 | 2M | 14.1% | 13 / 7 | 16 / 12 | 0M | 0M |
| Q2 2025 | 45 | 2M | 14.4% | 11 / 7 | 18 / 14 | 0M | 1M |
| Q1 2025 | 48 | 2M | 15.1% | 11 / 14 | 13 / 11 | 1M | 0M |
| Q4 2024 | 49 | 1M | 9.8% | 15 / 13 | 10 / 16 | 0M | 2M |
| Q3 2024 | 50 | 4M | 23.2% | 16 / 12 | 10 / 3 | 1M | 0M |
| Q2 2024 | 38 | 3M | 22.8% | 20 / 7 | 3 / 2 | 1M | 0M |
| Q1 2024 | 20 | 3M | 16.6% | 9 / 6 | 1 / 1 | 2M | 0M |
| Q4 2023 | 12 | 0M | 2.2% | 2 / 3 | 2 / 2 | 0M | 0M |
| Q3 2023 | 12 | 0M | 2.4% | 12 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CRVO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 250,174 | 1.65% | $775.54K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 66,028 | 0.44% | $204.69K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 37,241 | 0.25% | $115.82K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 19,545 | 0.13% | $60.59K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 9,020 | 0.06% | $28.05K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 8,992 | 0.06% | $27.97K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 7,411 | 0.05% | $23.05K | 0.00% | May 31, 2026 |
| Avantis U.S. Small Cap Equity ETF | 3,281 | 0.02% | $10.20K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 1,068 | 0.01% | $3.31K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John J. Alam | CEO & President, Director, 10% owner | 1,496,578 | 9.90% | Jun 10, 2026 |
| Matthew Winton | Chief Commercial and Business | 15,000 | 0.10% | Feb 13, 2026 |
| Rosch Mark De | EVP, RA and GA and PgM | – | – | Feb 13, 2026 |
| Kelly Blackburn | EVP, Clinical Development | 13,674 | 0.09% | Feb 13, 2026 |
| William Robert Elder | CFO, GC & Secretary | 12,500 | 0.08% | Feb 13, 2026 |
| Robert Joseph Cobuzzi Jr. | Chief Operating Officer | 1,616 | 0.01% | Feb 14, 2025 |
| Joshua S. Boger | Director, 10% owner | 2,012,682 | 13.31% | Jun 15, 2026 |
| Frank Zavrl | Director | 353,009 | 2.33% | Jun 10, 2026 |
| Jane H. Hollingsworth | Director | 943 | 0.01% | Jun 10, 2026 |
| Jeffrey V. Poulton | Director | – | – | Jun 10, 2026 |
| Marwan Sabbagh | Director | – | – | Jun 10, 2026 |
| David Quigley | Director | – | – | Jun 10, 2026 |
| Sylvie Gregoire | Director, 10% owner | 1,496,578 | 9.90% | Jun 10, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Joshua S. Boger Director, 10% owner | Jun 11, 2026 | Buy | +955,414 | $3.14 | $3.00M | 1,795,865 |
| Matthew Winton Chief Commercial and Business | Nov 18, 2025 | Buy | +1,500 | $7.95 | $11.93K | 15,000 |
| William Robert Elder CFO, GC & Secretary | Nov 18, 2025 | Buy | +2,500 | $8.32 | $20.80K | 12,500 |
| Matthew Winton Chief Commercial and Business | Nov 17, 2025 | Buy | +3,500 | $8.43 | $29.51K | 13,500 |
| John J. Alam CEO & President, Director, 10% owner | Nov 17, 2025 | Buy | +10,793 | $8.46 | $91.31K | 12,500 |
| John J. Alam CEO & President, Director, 10% owner | Nov 17, 2025 | Buy | +10,807 | $8.46 | $91.43K | 1,484,078 |
| William Robert Elder CFO, GC & Secretary | Nov 17, 2025 | Buy | +1,000 | $8.45 | $8.45K | 10,000 |
| Sylvie Gregoire Director, 10% owner | Nov 17, 2025 | Buy | +10,807 | $8.46 | $91.43K | 12,500 |
| Sylvie Gregoire Director, 10% owner | Nov 17, 2025 | Buy | +10,793 | $8.46 | $91.31K | 1,484,078 |
| Matthew Winton Chief Commercial and Business | Nov 14, 2025 | Buy | +10,000 | $7.57 | $75.70K | 10,000 |
| John J. Alam CEO & President, Director, 10% owner | Nov 14, 2025 | Buy | +1,693 | $7.55 | $12.78K | 1,473,271 |
| John J. Alam CEO & President, Director, 10% owner | Nov 14, 2025 | Buy | +1,707 | $7.57 | $12.92K | 1,707 |
| Sylvie Gregoire Director, 10% owner | Nov 14, 2025 | Buy | +1,707 | $7.57 | $12.92K | 1,473,285 |
| Sylvie Gregoire Director, 10% owner | Nov 14, 2025 | Buy | +1,693 | $7.55 | $12.78K | 1,693 |
| John J. Alam CEO & President, Director, 10% owner | Nov 13, 2025 | Buy | +4,447 | $7.51 | $33.40K | 1,471,578 |
| Sylvie Gregoire Director, 10% owner | Nov 13, 2025 | Buy | +4,447 | $7.51 | $33.40K | 1,471,578 |
| John J. Alam CEO & President, Director, 10% owner | Nov 12, 2025 | Buy | +5,553 | $7.35 | $40.81K | 1,467,131 |
| William Robert Elder CFO, GC & Secretary | Nov 12, 2025 | Buy | +3,500 | $7.44 | $26.04K | 9,000 |
| Sylvie Gregoire Director, 10% owner | Nov 12, 2025 | Buy | +5,553 | $7.35 | $40.81K | 1,467,131 |
| William Robert Elder CFO, GC & Secretary | May 14, 2025 | Buy | +4,233 | $8.46 | $35.81K | 5,500 |
| William Robert Elder CFO & GC | Aug 27, 2024 | Buy | +1,000 | $18.16 | $18.16K | 1,267 |
| Joshua S. Boger Director, 10% owner | Feb 26, 2024 | Sale | −36 | – | – | 840,451 |
| Joshua S. Boger Director, 10% owner | Feb 26, 2024 | Option exercise | +495,995 | – | – | 840,487 |
| Sylvie Gregoire Director, 10% owner | Nov 9, 2023 | Gift | −10,000 | – | – | 732,039 |
| John J. Alam CEO & President, Director, 10% owner | Nov 9, 2023 | Gift | −12,500 | – | – | 729,539 |
| Jane H. Hollingsworth Director | Aug 31, 2023 | Option exercise | +122 | – | – | 943 |
| Jane H. Hollingsworth Director | Aug 31, 2023 | Returned to company | −45 | – | – | 898 |
| Diana M. Lanchoney Director | Jun 30, 2023 | Returned to company | −85 | – | – | 294 |
| Diana M. Lanchoney Director | Jun 30, 2023 | Option exercise | +232 | – | – | 379 |
| Jane H. Hollingsworth Director | May 31, 2023 | Returned to company | −68 | – | – | 1,231 |
| Jane H. Hollingsworth Director | May 31, 2023 | Option exercise | +183 | – | – | 1,299 |
| Diana M. Lanchoney Director | Mar 31, 2023 | Option exercise | +232 | – | – | 232 |
| Diana M. Lanchoney Director | Mar 31, 2023 | Returned to company | −85 | – | – | 147 |
| Jane H. Hollingsworth Director | Feb 28, 2023 | Returned to company | −68 | – | – | 1,116 |
| Jane H. Hollingsworth Director | Feb 28, 2023 | Option exercise | +183 | – | – | 1,184 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Jan 31, 2023 | Returned to company | −121 | – | – | 1,616 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Jan 31, 2023 | Option exercise | +327 | – | – | 1,737 |
| Jane H. Hollingsworth Director | Nov 30, 2022 | Option exercise | +183 | – | – | 1,069 |
| Jane H. Hollingsworth Director | Nov 30, 2022 | Returned to company | −68 | – | – | 1,001 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Oct 31, 2022 | Returned to company | −121 | – | – | 1,410 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Oct 31, 2022 | Option exercise | +327 | – | – | 1,531 |
| Jane H. Hollingsworth Director | Aug 31, 2022 | Option exercise | +183 | – | – | 954 |
| Jane H. Hollingsworth Director | Aug 31, 2022 | Returned to company | −67 | – | – | 886 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Aug 1, 2022 | Returned to company | −121 | – | – | 1,204 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Aug 1, 2022 | Option exercise | +327 | – | – | 1,325 |
| Jane H. Hollingsworth Director | May 31, 2022 | Option exercise | +183 | – | – | 838 |
| Jane H. Hollingsworth Director | May 31, 2022 | Returned to company | −67 | – | – | 771 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | May 2, 2022 | Option exercise | +327 | – | – | 1,119 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | May 2, 2022 | Returned to company | −121 | – | – | 998 |
| William Robert Elder GC & Secretary | Apr 18, 2022 | Conversion | +100 | $25.00 | $2.50K | 400 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Apr 18, 2022 | Conversion | +100 | $25.00 | $2.50K | 792 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Jan 31, 2022 | Returned to company | −6,049 | – | – | 34,602 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Jan 31, 2022 | Option exercise | +16,350 | – | – | 40,651 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Nov 1, 2021 | Option exercise | +16,350 | – | – | 30,350 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Nov 1, 2021 | Returned to company | −6,049 | – | – | 24,301 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Nov 1, 2021 | Option exercise | +16,350 | – | – | 30,350 |
| Jane H. Hollingsworth Director | May 13, 2021 | Buy | +32,786 | $0.61 | $20.00K | 32,786 |
| William Robert Elder GC & Secretary | Nov 17, 2020 | Buy | +5,000 | $0.63 | $3.15K | 15,000 |
| William Robert Elder GC & Secretary | Nov 16, 2020 | Buy | +10,000 | $0.67 | $6.70K | 10,000 |
| Robert Joseph Cobuzzi Jr. President & CEO, Director | Nov 16, 2020 | Buy | +14,000 | $0.66 | $9.24K | 14,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.